Have you or a loved one taken any of the following Abilify medications?

Do not stop using these drugs without first consulting with your physician.

Abilify® Gambling Addiction Lawsuits

In May 2016, the FDA issued an official warning about impulse-control problems related to use of the drug Abilify®.

"The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify®, Abilify Maintena®, Aristada, and generics)."
U.S. Food and Drug Administration

FDA Safety Alerts

Patients and caregivers should be on alert for uncontrollable and excessive urges and behaviors while taking aripiprazole.

Abilify Lawsuit

These after-effects of Abilify® were enough to warrant multiple lawsuits filed against Bristol-Myers Squibb and Otsuka America Pharmaceuticals for failing to list all possible side effects of the drug.

Abilify® lawsuits have been filed against the Abilify® manufacturers by both patients and their families seeking compensation for injuries, including the severe emotional damage caused by this drug and these side effects.

Doctors issue 8.7 MILLION prescriptions of Abilify® a year, and this number is growing.

Abilify® Side-Effects inlcude Pathological Gambling, Hypersexuality, and Compulsive Shopping Behaviors

In December 2014, the JAMA International Medical Journal published an original investigation report titled “Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs.”

Research has suggested that Abilify® side-effects may impact an individual’s impulse control, leading to gambling addictions or other compulsive behavior that can have a horrifying impact on an individual’s financial situation, family, employment, emotional conditions, and overall quality of life.

Abilify® Settlement Amounts, Compensation and Victim Payouts

Abilify® is an antipsychotic drug with a list of devastating side effects, that manufacturers failed to properly warn the public of in a timely manner.

The U.S. Food and Drug Administration (FDA) initially approved Abilify® in 2002 as a treatment for schizophrenia.

The first Abilify® related settlement was for $515,000,000 and was finalized in 2007 between Bristol-Myers Squibb and the U.S. Justice Department.

Abilify Financial Loss

Multiple Abilify® Lawsuits are currently being filed against Bristol-Myers Squibb for failing to disclose the compulsive behaviors as a possible side effect of Abilify®, and settlement amounts for Abilify® lawsuits are likely to be substantial.

Abilify Addictions

Compulsive and often addictive behaviors caused by Abilify® include:

  • Overeating and weight gain
  • Stealing
  • Hypersexuality
  • Pathological gambling
  • Excessive shopping

Abilify® Lawsuit Commercials

Have you seen a commercial about Abilify® lawsuits?
You may have seen our “Compulsive Gambling Side-Effects” commercial
during one of your favorite nationally televised shows.

“Attention Abilify® users: the makers of Abilify® are under scrutiny after Abilify® was associated with compulsive behavior. If you have become a compulsive gambler while taking Abilify®, you may be entitled to a significant cash award. Compulsive gambling can have a devastating impact on patients' lives, even leading to severe financial harm. If you have become a compulsive gambler while taking Abilify®, you may be entitled to a significant cash award.”

Gambling problems
associated with Abilify®

Manufacturers of Abilify® market the drug as an additional treatment, which in combination with other anti-depressants can help to treat mental illnesses. However, this very popular drug is also linked to serious side effects like compulsive gambling and shopping, sexual dysfunction and even suicidal thoughts.

The Abilify® official boxed warning stated:

"Elderly people with psychosis related to dementia (for example, an inability to perform daily activities as a result of increased memory loss), treated with antipsychotic medicines including Abilify®, are at an increased risk of death compared to placebo. ABILIFY® is not approved for the treatment of people with dementia-related psychosis. Antidepressants may increase suicidal thoughts or behaviors in some children, teenagers, and young adults, especially within the first few months of treatment or when the dose is changed. ABILIFY® is not approved for use in pediatric patients with depression"

The most commonly cited side effect of Abilify® is compulsive gambling, with symptoms including:


Abilify Gambling Lawsuit
  • Taking increasingly bigger gambling risks
  • Dedicate all the free time and even time from work or family life to gamble
  • Escaping problems and/or feelings with gambling
  • Lying about gambling
  • Feeling guilt or remorse about gambling
  • Borrowing money and/or stealing to gamble
  • Failing to quit gambling

Do you qualify to File a Lawsuit against Abilify® Manufacturers?

Financial compensation may be available for individuals who have experienced a gambling problem while taking Abilify®.

Patients who were prescribed Abilify® for both approved and unapproved uses and who suffered severe consequences as a result may qualify to file an Abilify® dangerous drug lawsuit.

If you or your loved one has suffered from compulsive behaviors due to Abilify® use, please contact us immediately to have an attorney determine if you have a valid Abilify® case. Our experienced Abilify® lawyers have the required knowledge to review the facts of your situation to help determine if you are eligible to file a lawsuit against Abilify® manufacturers. Our attorneys dealing with Abilify® lawsuits provide free consultations.

Once you have spoken to an Abilify® lawsuit attorney, they will evaluate your case based on your unique facts.

If your answers meet the requirements for an Abilify® lawsuit, you may be eligible to receive financial compensation for Abilify® damages upon settlement of your case.

There are strict deadlines that must be met for Abilify® lawsuit settlements

Missed deadlines can result in ineligibility to receive a future settlement. To secure the best chance of being awarded a settlement, you should begin the process immediately. Please call or fill out the form right now to have a free evaluation of your Abilify® case.

Antipsychotic drug Abilify®

Abilify tablets

Aripiprazole, also known by its brand name Abilify® is an atypical antipsychotic drug. Abilify® can treat psychotic conditions like depression, schizophrenia, bipolar disorder, Tourette syndrome and others. It can also be prescribed to treat irritability associated with autism.

Aripiprazole was developed by Otsuka Pharmaceutical Co., Ltd. in Japan. In the United States, Otsuka America markets Abilify® jointly with Bristol-Myers Squibb. According to IMS Health, sales of Abilify® were more than $9 billion during 2014.

Schizophrenia is a relatively rare condition, and numbers of prescriptions for Abilify® were not significant for manufacturers. Otsuka and Bristol-Myers applied for FDA approval to use Abilify® for more conditions. Once the FDA approved other uses of Abilify®, the drug became a profitable resource for manufacturers.


In combination with other drugs, Abilify® is marketed today as an atypical antipsychotic drug for treating major depressions, bipolar disorder, and irritability associated with autism.